Cleared Traditional

K251247 - GX1 Radiofrequency Generator Kit (RFG-X1-120V) (FDA 510(k) Clearance)

Also includes:
GX1 Radiofrequency Generator Kit (RFG-X1-220V) GX1 Radiofrequency Generator Kit (RFG-X1-240V) GX1 System Release Rest of World (GX1-SYS-ROW) GX1 Radiofrequency Generator (51779845-01) GX1 Radiofrequency Generator (51779845-02) GX1 Radiofrequency Generator (51779845-03)

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K251247 · Boston Scientific Neuromodulation Corporation · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2025
Decision
106d
Days
Class 2
Risk

K251247 is an FDA 510(k) clearance for the GX1 Radiofrequency Generator Kit (RFG-X1-120V). Classified as Generator, Lesion, Radiofrequency (product code GXD), Class II - Special Controls.

Submitted by Boston Scientific Neuromodulation Corporation (Valencia, US). The FDA issued a Cleared decision on August 7, 2025 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Boston Scientific Neuromodulation Corporation devices

Submission Details

510(k) Number K251247 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 2025
Decision Date August 07, 2025
Days to Decision 106 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 148d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GXD Generator, Lesion, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXD Generator, Lesion, Radiofrequency

All 36
Devices cleared under the same product code (GXD) and FDA review panel - the closest regulatory comparables to K251247.
COOLIEF* Radiofrequency Generator (CRG-BASIC, CRG-BASIC-R, CRG-ADVANCED, CRG-ADVANCED-R)
K242057 · Avanos Medical, Inc. · Aug 2024
Racz Neurostat RF Generator
K232632 · Epimed International · May 2024
OneRF Ablation System
K231675 · Neuroone Medical Technologies Corp. · Dec 2023
APEX 6
K220122 · Rf Innovations, Inc. · Mar 2023
Abbott Medical Grounding Pad, model RF-DGP-IS
K203293 · Abbott Medical · Jan 2022